Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2022

Reconciliation of Numerators and Denominators used in Computing Basic and Diluted Net Income Per Share

The following is a reconciliation of the numerators and denominators used in computing basic and diluted net income per share:

	Three Months Ended						Nine Months Ended
	September 30, 2022			September 30, 2021			September 30, 2022			September 30, 2021
Net loss	$	(5,455,229	)	$	(4,085,297	)	$	(18,368,943	)	$	(10,033,014	)
Numerator, basic and diluted net loss available to stockholders	$	(5,455,229	)	$	(4,085,297	)	$	(18,368,943	)	$	(10,033,014	)
Denominator:
Shares used in computation – basic:
Weighted average common shares outstanding		19,482,118			13,273,241			16,569,240			12,971,591
Shares used in computation – diluted:
Weighted average common shares outstanding		19,482,118			13,273,241			16,569,240			12,971,591
Net loss per share – basic and diluted	$	(0.28	)	$	(0.31	)	$	(1.11	)	$	(0.77	)

In the Money Potential Common Shares [Member]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The potential common shares in the following tables represent potential common shares calculated using the if-converted method from outstanding options, stock awards and warrants that were excluded from the calculation of diluted EPS:

	Three Months Ended				Nine Months Ended
	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Average market price during the period	$	3.02	$	6.13	$	4.58		6.65
In the money potential common shares from options excluded		11,881		22,493		22,493		22,493
In the money potential common shares from warrants excluded		—		2,781,314		5,490,893		2,781,314

Out of Money Potential Common Shares [Member]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Potential common shares from out of the money options and warrants were also excluded from the computation of diluted EPS because calculation of the associated potential common shares has an anti-dilutive effect on EPS. The following table lists options and warrants that were excluded from diluted EPS:

	Three Months Ended		Nine Months Ended
Per share exercise price	September 30, 2022	September 30, 2021	September 30, 2022	September 30, 2021
Out of the money options excluded:
$3.42	3,091	—	—	—
$3.59	7,521	—	—	—
$12.48	136,833	136,833	136,833	136,833
$12.84	4,167	4,167	4,167	4,167
$26.40	75,158	75,158	75,158	75,158
Out-of-the-money warrants excluded:
$3.35	4,939,515	—	—	—
$3.99	551,378	—	—	—
$4.67	131,816	—	131,816	—
$4.75	1,873,622	—	1,873,622	—
$5.76	196,135	—	196,135	—
$7.16	700,000	700,000	700,000	700,000
Total excluded	8,619,236	916,158	3,117,731	916,158

Unvested Restricted Stock Awards Excluded from EPS [Member]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The equivalent common shares relating to our unvested restricted stock awards that were excluded from potential common shares in the earning per share calculation due to having an anti-dilutive effect are:

	Three Months Ended				Nine Months Ended
	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Excluded unvested restricted stock awards		294,184		497,350		294,184		497,350